Loading quotes...
Forecast
The analysts' average price target is €149.05 (+73.74%). The median is €145.60 (+69.72%).
| Buy |
21 |
| Hold |
20 |
| Sell |
5 |
Discussions in the community
- 4 7
- Performancevergleich bei Holding mit anderen Assets macht wenig Sinn?
Niklas Klamm III in Schnack8 2 - Watchlist: TURNAROUND Kandidaten - Strategie: abwarten bis sich die Gelegenheit ergibt...
MW Mario Watanabe IV in Schnack
5 2 - Fehlschläge
Das_Lama III in Schnack18 9 - 0 5
News Go to news feed
CEO change at Albemarle: Ragnar Udd to become president and CEO, shares fall
Albemarle announced that Ragnar Udd (currently chief commercial officer at BHP) will become president and CEO on February 1, 2027; current chairman and CEO Kent Masters will serve as executive chairman until the 2027 annual meeting. The announcement triggered an immediate negative market reaction, with the stock falling about 1.7% in the morning and materially underperforming the broader market. Analyst sentiment remains cautious; JPMorgan has already cut its price target from $160 to $140 while keeping its rating at neutral. Until Udd’s strategic priorities for the lithium and specialty chemicals business become clearer, the stock could remain under short-term pressure. » More on de.investing.com
Albemarle appoints BHP executive Ragnar Udd as next CEO
Albemarle has appointed Ragnar Udd as president and chief executive officer, effective 1 February 2027; Udd will also join the board. Current chairman and CEO Kent Masters will move into the role of executive chairman, and Gerald Steiner will remain lead independent director. Udd joins from BHP, where he serves as chief commercial officer on the executive leadership team and has more than 25 years of experience in the global commodities business. The appointment follows a comprehensive succession-planning process conducted by the board. » More on de.investing.com
Albemarle lifts revenue and EBITDA sharply, gives positive 2026 guidance
Albemarle reports Q1 2026 revenue up 32.7% to $1.43 billion and adjusted EBITDA of $663.8 million (+148%), driven by higher volumes and sharply higher lithium prices. Margin climbed to 46.5%, free cash flow was $247.6 million; net debt fell to $792.0 million after asset sales. Management gives a 2026 indication of revenue of $5.7–6.0 billion and adjusted EBITDA of $2.4–2.6 billion assuming an average LCE price of $20/kg, and plans further cost reductions as well as capital expenditures of $550–600 million. » More on finanzen.net
Moody’s raises outlook for Albemarle to 'stable' after improvement in metrics
Moody’s has raised the outlook for Albemarle from 'negative' to 'stable' and affirmed the Baa3 ratings and the Prime-3 rating. The agency cites significantly improved credit metrics following cost and capital expenditure cuts, divestitures and higher lithium prices. Albemarle reduced gross debt in Q1 2026 by $1.3 billion, adjusted leverage fell to 1.8x (previous year 4.5x), and the company has $1.1 billion in cash plus full access to a $1.5 billion revolving credit facility. Moody’s expects adjusted EBITDA of about $1.4 billion for 2026, assuming lithium prices of around 14 USD/kg. » More on de.investing.com
Albemarle boosts adjusted EBITDA by 148% in Q1 2026 as lithium market recovers
Albemarle reports adjusted EBITDA of $664m for Q1 2026 (+148% y/y) and adjusted diluted EPS of $2.95 compared with a loss a year earlier. Net revenue rose to $1.43bn (+33%); the energy storage segment generated $891m in revenue and adjusted EBITDA of $551m. Sold volume was 53,000 tonnes LCE at an average of $17/kg. The company reduced debt by $1.3bn, lowered its weighted interest rate and brought net debt/EBITDA to about 1.0x. Albemarle reaffirms scenario-based revenue and EBITDA guidance for 2026 and emphasizes productivity measures and sensitivity to lithium prices. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 1.37bn | 23.04% |
| Gross profit | 265.49m | 164.91% |
| Net profit | 261.99m | 291.33% |
| EBITDA | 290.83m | 824.03% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €10.13bn |
Number of shares | 118.01m |
52-week high/low | €199.86 - €81.18 |
Dividend yield | 1.65% |
Dividends TTM | €1.42 |
Beta | 1.36 |
P/E ratio | 21.77 |
PEG ratio | 0.00 |
P/B ratio | 1.06 |
P/S ratio | 1.82 |
Company profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
| Name | Albemarle Corporation |
| CEO | Jerry Kent Jr. |
| Headquarters | Charlotte,
nc USA |
| Website | |
| Sector | Materials |
| Industry | Chemicals |
| IPO | 22/02/1994 |
| Employees | 7,800 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | ALB |
London Stock Exchange | 0HC7.L |
XETRA | AMC.DE |
Frankfurt | AMC.F |
Düsseldorf | AMC.DU |
Hamburg | AMC.HM |
London | 0HC7.L |
SIX | AMCCHF.SW |
München | AMC.MU |
Wien | ALBE.VI |